CRISPR Therapeutics AG (CRSP)
51.30
+1.08
(+2.15%)
USD |
NASDAQ |
Oct 15, 12:57
CRISPR Therapeutics Total Long Term Debt (Quarterly) : 765.10M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 765.10M |
| March 31, 2026 | 769.03M |
| December 31, 2025 | 188.17M |
| September 30, 2025 | 192.77M |
| June 30, 2025 | 197.42M |
| March 31, 2025 | 201.85M |
| December 31, 2024 | 206.40M |
| September 30, 2024 | 210.66M |
| June 30, 2024 | 214.85M |
| March 31, 2024 | 218.94M |
| December 31, 2023 | 223.01M |
| September 30, 2023 | 226.58M |
| June 30, 2023 | 230.34M |
| March 31, 2023 | 224.55M |
| December 31, 2022 | 228.18M |
| September 30, 2022 | 230.90M |
| June 30, 2022 | 234.16M |
| March 31, 2022 | 227.90M |
| December 31, 2021 | 212.87M |
| September 30, 2021 | 192.73M |
| June 30, 2021 | 175.33M |
| March 31, 2021 | 49.41M |
| Date | Value |
|---|---|
| December 31, 2020 | 50.07M |
| September 30, 2020 | 38.57M |
| June 30, 2020 | 40.32M |
| March 31, 2020 | 42.39M |
| December 31, 2019 | 44.05M |
| September 30, 2019 | 36.83M |
| June 30, 2019 | 37.20M |
| March 31, 2019 | 31.73M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Basilea Pharmaceutica AG | 0.00 |
| Santhera Pharmaceuticals Holding AG | 0.00 |
| BeOne Medicines Ltd. | 1.808B |
| AC Immune SA | 5.085M |